Metabolic syndrome and the risk of chronic kidney disease
Journal Title: Нирки - Year 2017, Vol 6, Issue 2
Abstract
Metabolic syndrome (MS) is a combination of a disorder of carbohydrate metabolism, abdominal obesity, dyslipidemia and arterial hypertension. Studies show that there is a close relationship between MS and chronic kidney disease (CKD). Patients with MS have a 2.5-fold higher risk of CKD. Factors of CKD development in the metabolic syndrome are an increased level of insulin and insulin resistance, active forms of oxygen, inflammatory mediators, biologically active substances, hormones, inflammatory cytokines, an increase in the activity of coagulation factors, inhibition of the fibrinolytic system. Pathological abnormalities in the kidneys in patients with MS are manifested by microvascular tubular atrophy, interstitial fibrosis and global or segmental sclerosis. Microalbumin is an early marker for MS.
Authors and Affiliations
O. O. Melnyk
Ciprofloxacin in Urinary Tract Infection Treatment
Urinary tract infections occupy a leading place among nephrological pathology and infectious diseases in general. The article deals with the aetiology and key stages of the pathogenesis of urinary system lesions. The mai...
Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
.
Adsorptive-Rheological Properties of Blood Serum in Gouty Nephropathy
The aim and tasks of the study — to evaluate clinical-pathogenetic significance of changes in adsorptive rheological properties of blood serum (ARPB) in patients with different clinical courses of gouty nephropathy. Mate...
Kidneys and Diabetes Mellitus Type 2
.
Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...